TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
While we’re inundated with partisan nonsense over health care and Obamacare, the bipartisan FDA Reauthorization Act already allows Big Pharma to continue fleecing Americans. The circus sideshow of health care politics is providing yet another smokescreen for the real agenda of the corporate 2-party dictatorship. Contrary to the “different visions for America” portrayed by MSM Read More…
With the rapidly rising cost of prescriptions and the long list of side effects of most drugs, it should come as no surprise that it is not exactly big pharma’s top priority to consider what is in the patient’s best interest. What you might not realize, though, is that the government plays a large role in helping big Read More…
One of the few elected Democratic lawmakers with an extensive anti-war record, Rep. Tulsi Gabbard (D-Hawaii), has combined forces with Sen. Rand Paul (R-Kentucky) to push legislation through both the House and the Senate that would bar federal agencies from using taxpayer-backed funds to provide weapons, training, intelligence, or any other type of support to Read More…
“Years of complex operations and the ongoing demands of units in the field have left the armed forces struggling to maintain both operational capacity and high levels of readiness, according to a recent report from the Government Accountability Office.” That’s the opening paragraph of an article published by Business Insider last week. The piece, titled Read More…
A new study by the Boston Consulting Group has found that while wealth inequality is growing on a global scale, it has kicked into overdrive in the United States – where America’s 1% are expected to control 70 percent of the nation’s private wealth by the year 2021. America’s rich just won’t quit getting richer, Read More…
This article recounts key events along a time line that stretches from 1986 to the present. Follow the bouncing ball. Since Facebook went public with an IPO (Initial Public Offering) of stock in 2012, I’ve been following the trail of its stock price. In 2012, I wrote: “But now the Facebook stock has tanked. On Read More…